Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars. Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries. At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.
This report elaborates on the current development of the Biosimilar Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Biotech Pharma
Eli Lilly
CP Guojian Pharma
Amgen
By Type:
Tablets
Other Types
Injection
By Application:
Other Application
Tumor
Cardiovascular
Ankylosing Spondylitis
Rheumatoid Arthrtis
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilar Drug Market Overview 2018-2029
-
1.1 China Biosimilar Drug Industry Development Overview
-
1.2 China Biosimilar Drug Industry Development History
-
1.3 China Biosimilar Drug Industry Market Size (2018-2029)
-
1.4 China Biosimilar Drug Market Analysis by Type from Production Side
-
1.4.1 China Biosimilar Drug Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
1.4.2 China Biosimilar Drug Production Volume, Production Value and Growth Rate of Other Types (2018-2029)
-
1.4.3 China Biosimilar Drug Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
1.5 China Biosimilar Drug Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Other Application (2018-2029)
-
1.5.2 China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Tumor (2018-2029)
-
1.5.3 China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)
-
1.5.4 China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Ankylosing Spondylitis (2018-2029)
-
1.5.5 China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Rheumatoid Arthrtis (2018-2029)
-
1.6 China Biosimilar Drug Market Analysis by Region
-
1.6.1 North China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilar Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilar Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilar Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilar Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilar Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilar Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilar Drug Industry Development
Chapter 3 Biosimilar DrugIndustry Chain Analysis
-
3.1 Biosimilar Drug Industry Chain
-
3.2 Biosimilar Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilar Drug Market
-
3.3 Biosimilar Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilar Drug Market
Chapter 4 China Biosimilar Drug Market, by Type
-
4.1 China Biosimilar Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilar Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilar Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilar Drug Production Volume and Growth Rate of Tablets
-
4.5.2 China Biosimilar Drug Production Volume and Growth Rate of Other Types
-
4.5.3 China Biosimilar Drug Production Volume and Growth Rate of Injection
Chapter 5 China Biosimilar Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilar Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilar Drug Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilar Drug Market Size and Growth Rate of Other Application
-
5.5.2 China Biosimilar Drug Market Size and Growth Rate of Tumor
-
5.5.3 China Biosimilar Drug Market Size and Growth Rate of Cardiovascular
-
5.5.4 China Biosimilar Drug Market Size and Growth Rate of Ankylosing Spondylitis
-
5.5.5 China Biosimilar Drug Market Size and Growth Rate of Rheumatoid Arthrtis
Chapter 6 China Biosimilar Drug Market, by Region
-
6.1 China Biosimilar Drug Production Volume and Production Value, by Region
-
6.2 China Biosimilar Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilar Drug Market Analysis
-
7.1 North China Biosimilar Drug Market, by Type
-
7.2 North China Biosimilar Drug Market, by Application
Chapter 8 Central China Biosimilar Drug Market Analysis
-
8.1 Central China Biosimilar Drug Market, by Type
-
8.2 Central China Biosimilar Drug Market, by Application
Chapter 9 South China Biosimilar Drug Market Analysis
-
9.1 South China Biosimilar Drug Market, by Type
-
9.2 South China Biosimilar Drug Market, by Application
Chapter 10 East China Biosimilar Drug Market Analysis
-
10.1 East China Biosimilar Drug Market, by Type
-
10.2 East China Biosimilar Drug Market, by Application
Chapter 11 Northeast China Biosimilar Drug Market Analysis
-
11.1 Northeast China Biosimilar Drug Market, by Type
-
11.2 Northeast China Biosimilar Drug Market, by Application
Chapter 12 Southwest China Biosimilar Drug Market Analysis
-
12.1 Southwest China Biosimilar Drug Market, by Type
-
12.2 Southwest China Biosimilar Drug Market, by Application
Chapter 13 Northwest China Biosimilar Drug Market Analysis
-
13.1 Northwest China Biosimilar Drug Market, by Type
-
13.2 Northwest China Biosimilar Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Biotech Pharma
-
14.1.1 Biotech Pharma Company Profile
-
14.1.2 Biotech Pharma Biosimilar Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Profile
-
14.2.2 Eli Lilly Biosimilar Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 CP Guojian Pharma
-
14.3.1 CP Guojian Pharma Company Profile
-
14.3.2 CP Guojian Pharma Biosimilar Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Biosimilar Drug Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilar Drug Industry Research Conclusions
-
15.2 Biosimilar Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilar Drug Industry Market Size (2018-2029)
-
Figure China Biosimilar Drug Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
Figure China Biosimilar Drug Production Volume, Production Value and Growth Rate of Other Types (2018-2029)
-
Figure China Biosimilar Drug Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
Figure China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Other Application (2018-2029)
-
Figure China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Tumor (2018-2029)
-
Figure China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)
-
Figure China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Ankylosing Spondylitis (2018-2029)
-
Figure China Biosimilar Drug Sales Volume, Sales Value and Growth Rate of Rheumatoid Arthrtis (2018-2029)
-
Figure North China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilar Drug Market Size and Growth Rate from 2018-2029
-
Figure Biosimilar Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilar Drug Market Share by Type in 2018
-
Figure China Biosimilar Drug Market Share by Type in 2023
-
Figure China Biosimilar Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilar Drug Production Volume and Growth Rate of Tablets (2018-2023)
-
Figure China Biosimilar Drug Production Volume and Growth Rate of Other Types (2018-2023)
-
Figure China Biosimilar Drug Production Volume and Growth Rate of Injection (2018-2023)
-
Figure China Biosimilar Drug Market Share by Application in 2018
-
Figure China Biosimilar Drug Market Share by Application in 2023
-
Figure China Biosimilar Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilar Drug Market Size and Growth Rate of Other Application (2018-2023)
-
Figure China Biosimilar Drug Market Size and Growth Rate of Tumor (2018-2023)
-
Figure China Biosimilar Drug Market Size and Growth Rate of Cardiovascular (2018-2023)
-
Figure China Biosimilar Drug Market Size and Growth Rate of Ankylosing Spondylitis (2018-2023)
-
Figure China Biosimilar Drug Market Size and Growth Rate of Rheumatoid Arthrtis (2018-2023)
-
Table China Biosimilar Drug Production Volume by Region (2018-2023)
-
Table China Biosimilar Drug Production Volume Share by Region (2018-2023)
-
Figure China Biosimilar Drug Production Volume Share by Region (2018-2023)
-
Table China Biosimilar Drug Production Value by Region (2018-2023)
-
Table China Biosimilar Drug Production Value Share by Region (2018-2023)
-
Figure China Biosimilar Drug Production Value Share by Region (2018-2023)
-
Table China Biosimilar Drug Sales Volume by Region (2018-2023)
-
Table China Biosimilar Drug Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilar Drug Sales Volume Share by Region (2018-2023)
-
Table China Biosimilar Drug Sales Value by Region (2018-2023)
-
Table China Biosimilar Drug Sales Value Share by Region (2018-2023)
-
Figure China Biosimilar Drug Sales Value Share by Region (2018-2023)
-
Table North China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table North China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table North China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table North China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table Central China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table Central China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table South China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table South China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table South China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table East China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table East China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table East China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilar Drug Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilar Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilar Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilar Drug Sales Volume Share by Application (2018-2023)
-
Table Biotech Pharma Company Profile
-
Table Biotech Pharma Biosimilar Drug Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Biosimilar Drug Revenue, Price and Gross (2018-2023)
-
Table CP Guojian Pharma Company Profile
-
Table CP Guojian Pharma Biosimilar Drug Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Biosimilar Drug Revenue, Price and Gross (2018-2023)
-
